Rosuvastatin Calcium Tablet
Product Images NDC 68071-3623

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 68071-3623). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3623 9)

Pdp (68071 3623 9)
This text is outlining information related to a pharmaceutical product called Rosuvastatin 10mg tablets. It provides details such as the National Drug Code (NDC), lot number, manufacturer details, storage instructions, and warnings. It also mentions the active ingredient in the tablets, Rosuvastatin Calcium. This product is intended for adults and is to be taken according to the directions provided.*
FDA Label Image

Figure_1_time_jupiter (Rosuvastatin Tablets Figure 1)

Figure_1_time_jupiter (Rosuvastatin Tablets Figure 1)
This description provides hazard ratio (HR) of 0.56 with 95% confidence interval between 0.46 and 0.69. The p-value is shown to be less than 0.001. It also includes cumulative incidence percentages along with some numerical data related to different groups under study.*
FDA Label Image

Figure_2-major_jupiter (Rosuvastatin Tablets Figure 2)

Figure_2-major_jupiter (Rosuvastatin Tablets Figure 2)
This text provides data on the number of events in a study comparing the effects of Rosuvastatin 20 mg and placebo 20 mg. The analysis includes details on various endpoints such as the primary endpoint (MCE), cardiovascular death, non-fatal stroke, non-fatal MI, and arterial revascularization. Each endpoint is presented with the number of events, rates, hazard ratios, and corresponding P-values. The study involved a total of 8901 participants and investigated the impact of the medication on these specific outcomes.*
FDA Label Image

Figure_3_percent_dyslipidemia (Rosuvastatin Tablets Figure 3)

Figure_3_percent_dyslipidemia (Rosuvastatin Tablets Figure 3)
This text provides a list of different statin medications, including CRESTOR, Atorvastatin, Simvastatin, and Pravastatin, along with their corresponding doses in milligrams. The information appears to be related to the percentage change from an initial LDL cholesterol level.*
FDA Label Image
FDA Label Image

Logo1 (Rosuvastatin Tablets Logo2)

FDA Label Image

Structural_formula (Rosuvastatin Tablets Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.